Chemokine CXCL10 and Incident Stroke Risk in the Northern Manhattan Study
Translational Stroke Research · 2026
DOI: 10.1007/s12975-026-01498-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Stroke Research, 2026. Verfasst von Mohammad Nafeli Shahrestani und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA. mxn975@miami.edu. Hauptthemen laut MEDLINE: Chemokine CXCL10, Stroke. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institute on Aging (NIA).
Themen: Schlaganfall
Abstract (Originalsprache)
Inflammation contributes to cerebrovascular disease, but prospective studies of broad immune marker panels and incident stroke are limited. We aimed to identify plasma immune markers independently associated with incident stroke. Stroke-free Northern Manhattan Study participants aged ≥ 50 years had 60 plasma immune-related proteins measured by Luminex. Least absolute shrinkage and selection operator (LASSO) Cox regression selected markers associated with incident all-cause stroke. Selected markers were tested in Cox models of stroke risk sequentially adjusted for vascular risk, cardiac comorbidities, interleukin-6, interleukin-1β, tumor necrosis factor-α, and white matter hyperintensity volume (WMHV). Ischemic stroke was a secondary outcome, and bootstrap resampling provided internal validation. Among 1175 participants (mean age 70 ± 9 years; 60% women; 67% Hispanic), 130 strokes, 101 (78%) ischemic, occurred over a median of 14 years. LASSO selected only C-X-C motif chemokine ligands 9 and 10 (CXCL9 and CXCL10). Each 1-standard deviation greater CXCL10 was associated with 20% greater all-cause stroke risk after adjustment for vascular risk, cardiac comorbidities, and inflammatory cytokines (HR 1.20; 95%CI 1.04–1.38). The association persisted after WMHV adjustment (HR 1.18; 95%CI 1.02–1.37), was similar for ischemic stroke (HR 1.19; 95%CI 1.01–1.41), and was stable across bootstrap resamples. CXCL9 was not independently associated with stroke. In a multiethnic urban aging cohort followed prospectively for over a decade, baseline plasma CXCL10, also known as interferon-γ–induced protein 10 (IP-10), was independently associated with incident stroke. CXCL10 may mark interferon-γ–responsive immune activity linked to cerebrovascular vulnerability. Whether CXCL10 signals a modifiable pathway for stroke prevention warrants investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA. mxn975@miami.edu.
- Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, 1120 NW 14 Street, CRB 1371, Miami, FL, 33136, USA. mxn975@miami.edu.
- Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA.
- Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, 1120 NW 14 Street, CRB 1371, Miami, FL, 33136, USA.
- Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY, USA.
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- National Institute on Aging (NIA)
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Nafeli Shahrestani, M., Agudelo, C., Gardener, H., Veledar, E., Santiago, J. A., Di Tullio, M. R., Della-Morte, D., Aimagambetova, B., Gutierrez, J., Hornig, M., Elkind, M. S. V., Song, H., Wright, C. B., Tom, S. E., & Rundek, T. (2026). Chemokine CXCL10 and Incident Stroke Risk in the Northern Manhattan Study. Translational Stroke Research. https://doi.org/10.1007/s12975-026-01498-7
Vancouver
Nafeli Shahrestani M, Agudelo C, Gardener H, Veledar E, Santiago JA, Di Tullio MR, et al. Chemokine CXCL10 and Incident Stroke Risk in the Northern Manhattan Study. Translational Stroke Research. 2026. doi:10.1007/s12975-026-01498-7
BibTeX
@article{NafeliShahrestani2026,
author = {Nafeli Shahrestani, Mohammad and Agudelo, Christian and Gardener, Hannah and Veledar, Emir and Santiago, Jose A and Di Tullio, Marco R and Della-Morte, David and Aimagambetova, Botagoz and Gutierrez, Jose and Hornig, Mady and Elkind, Mitchell S V and Song, Hyun and Wright, Clinton B and Tom, Sarah E and Rundek, Tatjana},
title = {Chemokine CXCL10 and Incident Stroke Risk in the Northern Manhattan Study},
journal = {Translational Stroke Research},
year = {2026},
doi = {10.1007/s12975-026-01498-7}
}
EUVIMED